The Role of Conventional MR and CT in the Work-Up of Dementia Patients

Magnetic Resonance Imaging Clinics of North America

Volumn 14, Issue 2, 2006, Pages 169-182

  Keyserling, Harold ^a   Mukundan Jr , Srinivasan ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ALZHEIMER DISEASE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; BRAIN VENTRICLE; CADASIL; COMPUTER ASSISTED TOMOGRAPHY; CORTICOBASAL DEGENERATION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; GRAY MATTER; HEMISPHERE; HIPPOCAMPUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROSYPHILIS; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; TEMPORAL LOBE; TREPONEMA PALLIDUM; VASCULAR AMYLOIDOSIS; WHITE MATTER;

EID: 33746239085     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2006.06.001     Document Type: Review

References (93)

1. Hsu Y.Y., Du A.T., Schuff N., et al. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 14 (2001) 145-166
2. Bozzao A., Floris R., Baviera M.E., et al. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 22 (2001) 1030-1036
3. National Institute of Neurological Disorders and Stroke. The dementias: hope through research. Available at: http://www.ninds.nih.gov/disorders/alzheimersdisease/detail_alzheimersdisease.htm. Accessed November 2005.
4. Maurer K., Volk S., et al. and Alzheimer's disease. Lancet 349 (1997) 1546-1549
5. Alzheimer A. Über eigenartige Krankheitsfälle des späteren Alters. Z Gesamte Neurol Psychiatrie 4 (1911) 356-385
6. Jellinger K. Morphology of Alzheimer disease and related disorders. In: Maurer K., Riederer P., and Beckmann H. (Eds). Alzheimer disease: epidemiology, neuropathology and clinics (1990), Springer-Verlag, New York 61-77
7. Hyman B.T., and Trojanowski J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56 (1997) 1095-1097
8. Mirra S.S., Heyman A., McKeel D.W., et al. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
9. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
10. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
11. Larson E.B., Edwards J.K., O'Meara E., et al. Neuropathologic diagnostic outcomes from a cohort of outpatients with suspected dementia. J Gerontol A Biol Sci Med Sci 51 Suppl 6 (1996) M313-M318
12. Rasmusson D.X., Brandt J., Steele C., et al. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 10 (1996) 180-188
13. Xiong G., and Doraiswamy P.M. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?. Geriatrics 60 (2005) 22-26
14. Seab J.P., Jagust W.J., Wong S.T., et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 8 (1988) 200-208
15. Kesslak J.P., Nalcioglu O., and Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 41 (1991) 51-54
16. Jack C.R. Structural imaging approaches to Alzheimer's disease. In: Daffner S. (Ed). Early diagnosis of Alzheimer's disease (2000), Humana, Totowa (NJ) 127-148
17. Jack Jr. C.R., Petersen R.C., Xu Y., et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55 (2000) 484-489
18. de Leon M.J., George A.E., Stylopoulos L.A., et al. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 2 (1989) 672-673
19. Roman G.C. Facts, myths, and controversies in vascular dementia. J Neurol Sci 226 (2004) 49-52
20. Roman G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
21. Ballard C.G., Burton E.J., Barber R., et al. NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology 63 (2004) 983-988
22. Roman G.C., Erkinjuntti T., Wallin A., et al. Subcortical ischaemic vascular dementia. Lancet Neurol 1 (2002) 426-436
23. Ringelstein E.B., and Nabavi D.G. Cerebral small vessel diseases: cerebral microangiopathies. Curr Opin Neurol 18 (2005) 179-188
24. Fazekas F., Chawluk J.B., Alavi A., et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149 (1987) 351-356
25. Bowen B.C., Barker W.W., Loewenstein D.A., et al. MR signal abnormalities in memory disorder and dementia. AJR Am J Roentgenol 154 (1990) 1285-1292
26. Gladstone J.P., and Dodick D.W. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist 11 (2005) 19-29
27. Dichgans M. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: phenotypic and mutational spectrum. J Neurol Sci 203-204 (2002) 77-80
28. Skehan S.J., Hutchinson M., and MacErlaine D.P. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. AJNR Am J Neuroradiol 16 (1995) 2115-2119
29. Fattapposta F., Restuccia R., Pirro C., et al. Early diagnosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): the role of MRI. Funct Neurol 19 (2004) 239-242
30. Remes A.M., Finnila S., Mononen H., et al. Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy. Neurology 63 (2004) 234-240
31. van Straaten E.C., Scheltens P., and Barkhof F. MRI and CT in the diagnosis of vascular dementia. J Neurol Sci 226 (2004) 9-12
32. Smith E.E., Gurol M.E., Eng J.A., et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 63 (2004) 1606-1612
33. Walker D.A., Broderick D.F., Kotsenas A.L., et al. Routine use of gradient-echo MRI to screen for cerebral amyloid angiopathy in elderly patients. AJR Am J Roentgenol 182 (2004) 1547-1550
34. *-weighted magnetic resonance imaging are associated with past history of small vessel disease in patients with intracerebral hemorrhage. J Neuroimaging 14 (2004) 251-257
35. Patel S.H., Kolson D.L., Glosser G., et al. Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. AJNR Am J Neuroradiol 23 (2002) 543-549
36. Gonzalez R.G. Imaging neuroAIDS. AJNR Am J Neuroradiol 25 (2004) 167-168
37. Avison M.J., Nath A., and Berger J.R. Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?. Trends Neurosci 25 (2002) 468-473
38. Manji H., and Miller R. The neurology of HIV infection. J Neurol Neurosurg Psychiatry 75 Suppl 1 (2004) i29-i35
39. Tucker K.A., Robertson K.R., Lin W., et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol 157 (2004) 153-162
40. Tien R.D., Felsberg G.J., Ferris N.J., et al. The dementias: correlation of clinical features, pathophysiology, and neuroradiology. AJR Am J Roentgenol 161 (1993) 245-255
41. Langford T.D., Letendre S.L., Marcotte T.D., et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16 (2002) 1019-1029
42. von Einsiedel R.W., Fife T.D., Aksamit A.J., et al. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 240 (1993) 391-406
43. Fong I.W., and Toma E. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group. Clin Infect Dis 20 (1995) 1305-1310
44. Albrecht H., Hoffmann C., Degen O., et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12 (1998) 1149-1154
45. Thurnher M.M., Thurnher S.A., Muhlbauer B., et al. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 39 (1997) 611-618
46. Whiteman M.L., Post M.J., Berger J.R., et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187 (1993) 233-240
47. Collie D.A., Summers D.M., Sellar R.J., et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 24 (2003) 1560-1569
48. Matsusue E., Kinoshita T., Sugihara S., et al. White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 25 (2004) 910-918
49. Schaefer P.W., Grant P.E., and Gonzalez R.G. Diffusion-weighted MR imaging of the brain. Radiology 217 (2000) 331-345
50. Mao-Draayer Y., Braff S.P., Nagle K.J., et al. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. AJNR Am J Neuroradiol 23 (2002) 550-556
51. Shiga Y., Miyazawa K., Sato S., et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 63 (2004) 443-449
52. Stadnik T.W., Demaerel P., Luypaert R.R., et al. Imaging tutorial: differential diagnosis of bright lesions on diffusion-weighted MR images. Radiographics 23 (2003) e7
53. Mendez O.E., Shang J., Jungreis C.A., et al. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?. J Neuroimaging 13 (2003) 147-151
54. Fox P.A., Hawkins D.A., and Dawson S. Dementia following an acute presentation of meningovascular neurosyphilis in an HIV-1 positive patient. AIDS 14 (2000) 2062-2063
55. Holland B.A., Perrett L.V., and Mills C.M. Meningovascular syphilis: CT and MR findings. Radiology 158 (1986) 439-442
56. Kodama K., Okada S., Komatsu N., et al. Relationship between MRI findings and prognosis for patients with general paresis. J Neuropsychiatry Clin Neurosci 12 (2000) 246-250
57. Zifko U., Wimberger D., Lindner K., et al. MRI in patients with general paresis. Neuroradiology 38 (1996) 120-123
58. Berbel-Garcia A., Porta-Etessam J., Martinez-Salio A., et al. Magnetic resonance image-reversible findings in a patient with general paresis. Sex Transm Dis 31 (2004) 350-352
59. Cosottini M., Mascalchi M., Zaccara G., et al. Reversal of syphilitic hydrocephalus with intravenous penicillin. Can J Neurol Sci 24 (1997) 343-344
60. Kitagaki H., Mori E., Ishii K., et al. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 19 (1998) 1277-1284
61. Golomb J., de Leon M.J., George A.E., et al. Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 57 (1994) 590-593
62. Savolainen S., Laakso M.P., Paljarvi L., et al. MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis. AJNR Am J Neuroradiol 21 (2000) 409-414
63. Holodny A.I., Waxman R., George A.E., et al. MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. AJNR Am J Neuroradiol 19 (1998) 813-819
64. Bradley W.G. Normal pressure hydrocephalus: new concepts on etiology and diagnosis. AJNR Am J Neuroradiol 21 (2000) 1586-1590
65. Kitagaki H., Mori E., Yamaji S., et al. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology 208 (1998) 431-439
66. Kertesz A., and Munoz D. Pick's disease, frontotemporal dementia, and Pick complex: emerging concepts. Arch Neurol 55 (1998) 302-304
67. Baskys A. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms. J Clin Psychiatry 65 Suppl 11 (2004) 16-22
68. McKeith I.G. Dementia with Lewy bodies. Br J Psychiatry 180 (2002) 144-147
69. Bozzali M., Falini A., Cercignani M., et al. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain (2005) in press
70. Cousins D.A., Burton E.J., Burn D., et al. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology 61 (2003) 1191-1195
71. Tam C.W., Burton E.J., McKeith I.G., et al. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64 (2005) 861-865
72. Emre M. Dementia in Parkinson's disease: cause and treatment. Curr Opin Neurol 17 (2004) 399-404
73. Lieberman A., Dziatolowski M., Kupersmith M., et al. Dementia in Parkinson disease. Ann Neurol 6 (1979) 355-359
74. McKeith I.G., and Mosimann U.P. Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord 10 Suppl 1 (2004) S15-S18
75. Tsuboi Y., and Dickson D.W. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?. Parkinsonism Relat Disord 11 Suppl 1 (2005) S47-S51
76. Bertrand E., Lechowicz W., Szpak G.M., et al. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia. Folia Neuropathol 42 (2004) 141-150
77. Huber S.J., Shuttleworth E.C., Christy J.A., et al. Magnetic resonance imaging in dementia of Parkinson's disease. J Neurol Neurosurg Psychiatry 52 (1989) 1221-1227
78. Braffman B.H., Grossman R.I., Goldberg H.I., et al. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. AJR Am J Roentgenol 152 (1989) 159-165
79. Huber S.J., Chakeres D.W., Paulson G.W., et al. Magnetic resonance imaging in Parkinson's disease. Arch Neurol 47 (1990) 735-737
80. Litvan I. Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 18 Suppl 6 (2003) S43-S50
81. Cordato N.J., Duggins A.J., Halliday G.M., et al. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128 (2005) 1595-1604
82. Paviour D.C., Price S.L., Stevens J.M., et al. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64 (2005) 675-679
83. Righini A., Antonini A., De Notaris R., et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 25 (2004) 927-932
84. Paviour D.C., Schott J.M., Stevens J.M., et al. Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75 (2004) 1772-1775
85. Kertesz A., Martinez-Lage P., Davidson W., et al. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55 (2000) 1368-1375
86. Stover N.P., and Watts R.L. Corticobasal degeneration. Semin Neurol 21 (2001) 49-58
87. Tsuchiya K., Miyazaki H., Ikeda K., et al. Serial brain CT in corticobasal degeneration: radiological and pathological correlation of two autopsy cases. J Neurol Sci 152 (1997) 23-29
88. Kitagaki H., Hirono N., Ishii K., et al. Corticobasal degeneration: evaluation of cortical atrophy by means of hemispheric surface display generated with MR images. Radiology 216 (2000) 31-38
89. Soliveri P., Monza D., Paridi D., et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 53 (1999) 502-507
90. Aylward E.H., Schwartz J., Machlin S., et al. Bicaudate ratio as a measure of caudate volume on MR images. AJNR Am J Neuroradiol 12 (1991) 1217-1222
91. Aylward E.H., Anderson N.B., Bylsma F.W., et al. Frontal lobe volume in patients with Huntington's disease. Neurology 50 (1998) 252-258
92. Kassubek J., Juengling F.D., Kioschies T., et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 75 (2004) 213-220
93. Ho V.B., Chuang H.S., Rovira M.J., et al. Juvenile Huntington disease: CT and MR features. AJNR Am J Neuroradiol 16 (1995) 1405-1412